Alpine Immune Stock Forecast - Rate Of Daily Change

ALPNDelisted Stock  USD 12.37  0.23  1.83%   
Alpine Stock Forecast is based on your current time horizon.
  
Alpine Immune Sciences has current Rate Of Daily Change of 0.98. Rate Of Daily Change (RDOC) indicator calculates rate of change of a given period over the current closing price of Alpine Immune.
Check Alpine Immune VolatilityBacktest Alpine ImmuneInformation Ratio  

Alpine Immune Trading Date Momentum

On December 12 2024 Alpine Immune Sciences was traded for  12.37  at the closing time. The top price for the day was 12.64  and the lowest listed price was  12.14 . There was no trading activity during the period 0.0. Lack of trading volume on December 12, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.86% .
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
Compare Alpine Immune to competition

View Alpine Immune Related Equities

 Risk & Return  Correlation

Alpine Immune Market Strength Events

Market strength indicators help investors to evaluate how Alpine Immune stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alpine Immune shares will generate the highest return on investment. By undertsting and applying Alpine Immune stock market strength indicators, traders can identify Alpine Immune Sciences entry and exit signals to maximize returns.

Alpine Immune Risk Indicators

The analysis of Alpine Immune's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Alpine Immune's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting alpine stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Alpine Stock

If you are still planning to invest in Alpine Immune Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpine Immune's history and understand the potential risks before investing.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bonds Directory
Find actively traded corporate debentures issued by US companies
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
CEOs Directory
Screen CEOs from public companies around the world